Cannabis Bioscience International Holdings (CBIH) Cash from Financing Activities (2023 - 2025)

Cannabis Bioscience International Holdings has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $156716.0 for Q2 2025.

• Cash from Financing Activities for Q2 2025 came in at $156716.0, down 10.14% year-over-year; the trailing twelve-month figure through May 2025 was $341824.0 (down 27.46% YoY), and the FY2025 annual result was $341824.0, down 27.46% from the prior year.
• Cash from Financing Activities came in at $156716.0 for Q2 2025 at Cannabis Bioscience International Holdings, up from $82358.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $216837.0 in Q4 2023 to a low of $9534.0 in Q1 2024.
• The 3-year median for Cash from Financing Activities is $119537.0 (2025), against an average of $118690.2.
• Across the five-year window, Cash from Financing Activities slumped 95.3% in 2024 and soared 763.83% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Cash from Financing Activities stood at $216837.0 in 2023, then tumbled by 66.74% to $72123.0 in 2024, then surged by 117.29% to $156716.0 in 2025.
• The last three Cash from Financing Activities figures came in at $156716.0 (Q2 2025), $82358.0 (Q1 2025), and $72123.0 (Q4 2024), per Business Quant data.